Skip to main content
Category

News Archive

Epidarex Logo

Epidarex | LUNAC Therapeutics Spun Out to Develop Next Generation Anticoagulants, and Announces Series A Funding Round – Epidarex

By News Archive

Epidarex Logo

Leeds, UK, 14 November 2019: LUNAC Therapeutics (LUNAC), a UK based drug discovery company focused on the identification and development of advanced anticoagulants with minimal bleeding risk, today announced it has spun out of the University of Leeds with £2.65M funding in the first close of a Series A financing round. The investment is being led by Epidarex Capital and the University of Leeds. The Company was founded based on IP generated by Prof Helen Philippou and Dr Richard Foster, through unique insights built on a decade of academic research into Factor XII which has been supported by the Wellcome Trust, British Heart Foundation and the Medical Research Council.

 

Read More
Handshake Hand Give Free photo on Pixabay

Qiagen Shares Jump as Thermo Fisher Is Said to Weigh Acquisition – Bloomberg

By News Archive

Handshake Hand Give Free photo on Pixabay

Qiagen NV shares jumped the most in 17 years after people with knowledge of the matter said Thermo Fisher Scientific Inc. is considering a takeover of the molecular testing firm.

Thermo Fisher has approached the Dutch company about a potential purchase that could become one of its biggest-ever acquisitions, the people said, asking not to be identified because the information is private. Shares of Qiagen rose 13% to 33.20 euros at 1:10 p.m. in Frankfurt, giving it a market value of $8.3 billion.

 

Read More
Laboratory Scientists Research Free photo on Pixabay

GSK and Montgomery College Partner on New Apprenticeship Program to Meet Growing Demands for Biomanufacturing Workforce in Maryland · BioBuzz

By News Archive

ELaboratory Scientists Research Free photo on Pixabayarlier this year we reported on the First of Its Kind Apprenticeship Program at GSK’s Rockville, Maryland Site. We are happy to provide an update on that story with news that GlaxoSmithKline (GSK) has expanded their apprenticeship program to now include Biopharmaceutical Associates.

GSK is an industry-leading pharmaceutical, consumer products and healthcare company and is known for taking a future-oriented approach to their talent strategies. The Validation Technician Apprenticeship was the first of its kind in the U.S. pharmaceutical industry. They have also begun to explore Virtual Reality training as a model that can be used to speed up employee development.

 

Read More
Sara Gilgore

Children’s National Hospital taps Virginia Tech for Walter Reed campus – Washington Business Journal

By News Archive

Sara Gilgore

Virginia Tech is coming to Children’s National Hospital’s new campus at the former Walter Reed Army Medical Center.

The partnership will bring a 12,000-square-foot biomedical research complex to the 12-acre Children’s National Research and Innovation Campus, slated to deliver in December 2020 as part of the project’s first phase. In the university’s first D.C. location, Virginia Tech’s Fralin Biomedical Research Institute at Virginia Tech Carilion will establish a D.C. team to work with Children’s National on translational research projects, faculty recruiting, intellectual property work and commercialization, and trainings for students and fellows — all focused on pediatric cancers of the brain and nervous system.

 

Read More
Johns Hopkins Launches Hub for Immunology and Engineering Research

Johns Hopkins Launches Hub for Immunology and Engineering Research

By News Archive

Johns Hopkins Launches Hub for Immunology and Engineering Research

Newswise — If the saying that two heads are better than one is true, then joining two fields of science may be better than one to spur more advances in medicine. With a $6.7 million, five-year grant from the National Institutes of Health, Johns Hopkins Medicine researchers will bring together immunologists, oncologists and biomedical engineers in an effort to build new tools to treat cancer and autoimmune diseases.

 

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.